Date: 18.2.2015
A High-Throughput Screening (HTS) facility utilising a number of cutting edge technologies to enable scientists to conduct translational science in the field of drug discovery. Summary: |
|
A UK University which is committed to being at the vanguard of academic-led drug discovery and the search for the next generation of therapies that will benefit humankind, has developed a new High-Throughput Screening (HTS) facility. This facility contains a number of cutting edge technologies that are required to enable scientists to conduct translational science in the drug discovery field. Partners are sought for joint venture, technical, research or commercial collaboration agreements. |
|
Reference: |
TOUK20140916001 |
Country: |
United Kingdom |
Submitted: |
Dec 12 2014 |
Updated: |
Feb 06 2015 |
KEYWORDS |
|
Market: |
Cellular and Molecular Biology, Chromatographs and related laboratory equipment (including spectrometers) , Microbiology , Other analytical and scientific instrumentation , Pharmaceuticals/fine chemicals |
Technology: |
Cellular and Molecular Biology, Medical Research , Microbiology , Pharmaceutical Products / Drugs , Pharmaceutics |
NACE: |
Other human health activities, Other professional, scientific and technical activities n.e.c. , Other research and experimental development on natural sciences and engineering , Research and experimental development on biotechnology , Technical testing and analysis |
Technologické nabídky a poptávky zpracovává BIC Plzeň, partner sítě Enterprise Europe Network.
Gate2Biotech - Biotechnology Portal - All Czech Biotechnology information in one place.
ISSN 1802-2685
This website is maintained by: CREOS CZ
© 2006 - 2024 South Bohemian Agency for Support to Innovative Enterprising (JAIP)
Interesting biotechnology content:
Biotechnology legislative - Biotech legislative environment search
Biotechnology organizations - Biotech research institute, company, university, ..
Respiratory bacteria turn off immune system to survive, study finds
New method uses nanoparticles to reprogram exhausted immune cells